This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Treatment and prevention of folliculitis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Local measures:

  • cleaning - use chlorhexidine and apply saline or aluminium subacetate soaks / compresses for 15 minutes, twice daily. Open the larger pustules and trim away any necrotic tissue. Anhydrous ethyl alcohol containing 6.25% aluminium chloride may be helpful.

General measures:

  • systemic antibiotics e.g. flucloxacillin or clarithromycin (if penicillin-allergic) - only if local treatment is ineffective; the infection is severe; or has become complicated or involves the upper lip, nose or eyes from which a cavernous sinus thrombosis may develop
    • in general a 7 day course of antibiotic treatment is indicated for acute folliculitis (1,2,3,4)
      • for some cases of folliculitis a course of oral antibiotics may be administered over 7 to 10 days (5)

    • chronic folliculitis may require prolonged antibiotic treatment e.g. oxytetracycline for 6-8 weeks (however in cases of chronic folliculitis it is important to swab lesions and consult with local microbiological advice regarding antibiotic prescribing) (6)

    • for antibiotic-resistant S aureus then consult local guidance
      • clindamycin, tetracyclines, trimethoprim-sulfamethoxazole, linezolid, or glycopeptide (e.g.parenteral vancomycin) may be used (7)

  • topical 2% mupirocin - 3 times daily and supported with dressings. Particularly valuable in eliminating primary or secondary infection.

Specific forms of folliculitis:

  • hot tub folliculitis - pseudomonas folliculitis is a benign, self-limited disorder (2) Showering after exposure to contaminated water does not seem to prevent the disease
    • hot water, a high pH, and low chlorine levels all predispose to infection - pseudomonas folliculitis can be prevented by proper maintenance and chlorination of pools, hot tubs, whirlpools, and spas to decrease the population of P. aeruginosa
    • antibiotic treatment with ciprofloxacin may be used
      • use of systemic antimicrobial agents should be considered in patients with fever and constitutional symptoms or in patients with resistant disease (3)

  • gram-negative folliculitis
    • sometimes failure to respond to antibiotic therapy is due to development of gram-negative folliculitis
      • high dose trimethoprim - 300mg bd in adults - is the antibiotic of choice in these situations (3)
      • isotretinoin has been successfully used to treat different forms of folliculitis including gram-negative folliculitis and HIV-associated eosinophilic folliculitis (4)

Prevention:

  • correct precipitating factors:
    • systemic eg. diabetes mellitus
    • local eg. irritations, discharges

Reference:

  • (1) Prescriber (2004); 15 (13): 35-40.
  • (2) Yu Y et al. Hot tub folliculitis or hot hand-foot syndrome caused by Pseudomonas aeruginosa. J Am Acad Dermatol. 2007 Oct;57(4):596-600. Epub 2007 Jul 19.
  • (3) Pulse (3/10/07):49.
  • (4) Dermatology in Practice 2007;15(4):26-28.
  • (5) Laureano AC et al. Facial bacterial infections: folliculitis. Clinics in Dermatology 2014;2(6):711-4.
  • (6) Personal communication (23/5/12). Dr P Kenyon (GPSI Dermatology, Rugby Hospital)
  • (7) Nagaraju U et al. Methicillin resistant Staphylococcus aureus in community-acquired pyoderma. International Journal of Dermatology 2004;43(6):412-4.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.